Literature DB >> 17221866

Low proportion of whole exon deletions causing phenylketonuria in Denmark and Germany.

Lisbeth Birk Møller1, Anders O H Nygren, Patrick Scott, Pia Hougaard, Jytte Bieber Nielsen, Caroline Hartmann, Flemming Güttler, Linda Tyfield, Johannes Zschocke.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive genetic disorder caused by mutations of the gene encoding phenylalanine hydroxylase (PAH). More than 500 different PAH mutations have been identified and about 90% of these are single base mutations. Although the identification rate of the PAH mutations is generally very high, some variants remain unidentified. A fraction of these mutations are the result of genomic deletions or duplications, which are not recognized with standard PCR-based methods. Here we present the results of exon deletion or duplication analysis in a total of 34 families, in which two mutations had not been identified using conventional diagnostic screening techniques. Using multiplex ligation-dependent probe amplification (MLPA), we found a deletion covering exon 1 and exon 2 (c.1-?_168+?del) in one patient, a deletion of exon 3 (c.169-?_352+?del) in four patients, and a deletion of exon 5 (c.442-?_509+?del) in two patients. A deletion was thus detected in about 20% (7/34) of the families tested. Out of a combined cohort of 570 independent PKU patients from Denmark and Germany, exon deletions were identified in a total of four patients. The estimated allelic frequency of exon deletions in PKU patients in these two populations is therefore below 0.5%. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221866     DOI: 10.1002/humu.9481

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Clinical utility gene card for: Phenylketonuria.

Authors:  Johannes Zschocke; Thomas Haverkamp; Lisbeth Birk Møller
Journal:  Eur J Hum Genet       Date:  2011-09-14       Impact factor: 4.246

2.  A novel large deletion (exons 12, 13) and a missense mutation (p.G46R) in the PAH in a Japanese patient with phenylketonuria.

Authors:  Yoshihiro Maruo; Masafumi Suzaki; Katsuyuki Matsui; Yu Mimura; Asami Mori; Haruo Shintaku; Yoshihiro Takeuchi
Journal:  World J Pediatr       Date:  2015-04-30       Impact factor: 2.764

3.  Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients.

Authors:  Elisabeth Sterl; Karl Paul; Eduard Paschke; Johannes Zschocke; Michaela Brunner-Krainz; Eva Windisch; Vassiliki Konstantopoulou; Dorothea Möslinger; Daniela Karall; Sabine Scholl-Bürgi; Wolfgang Sperl; Florian Lagler; Barbara Plecko
Journal:  J Inherit Metab Dis       Date:  2012-04-25       Impact factor: 4.982

4.  The study of the full spectrum of variants leading to hyperphenylalaninemia have revealed 10 new variants in the PAH gene.

Authors:  I Kuznetcova; P Gundorova; O Ryzhkova; A Polyakov
Journal:  Metab Brain Dis       Date:  2019-07-22       Impact factor: 3.584

5.  Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria.

Authors:  Yong Wha Lee; Dong Hwan Lee; Nam Doo Kim; Seung Tae Lee; Jee Young Ahn; Tae Youn Choi; You Kyoung Lee; Sun Hee Kim; Jong Won Kim; Chang Seok Ki
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

6.  Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics.

Authors:  Francesco Cali; Giuseppa Ruggeri; Mirella Vinci; Concetta Meli; Carla Carducci; Vincenzo Leuzzi; Simone Pozzessere; Pietro Schinocca; Alda Ragalmuto; Valeria Chiavetta; Salvatore Micciche; Valentinox Romano
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

7.  The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

Authors:  Gladys Ho; Ian Alexander; Kaustuv Bhattacharya; Barbara Dennison; Carolyn Ellaway; Sue Thompson; Bridget Wilcken; John Christodoulou
Journal:  JIMD Rep       Date:  2013-12-25

8.  Quality of diagnostic mutation analyses for phenylketonuria.

Authors:  J Zschocke; C Aulehla-Scholz; S Patton
Journal:  J Inherit Metab Dis       Date:  2008-11-21       Impact factor: 4.982

Review 9.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

10.  DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variant.

Authors:  Kısmet Çıkı; Yılmaz Yıldız; Didem Yücel Yılmaz; Emine Pektaş; Ayşegül Tokatlı; R Köksal Özgül; H Serap Sivri; Ali Dursun
Journal:  Metab Brain Dis       Date:  2021-05-20       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.